Federated Hermes’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,778
Closed -$580K 2234
2025
Q2
$580K Buy
15,778
+15,720
+27,103% +$543K ﹤0.01% 1299
2025
Q1
$2.28K Buy
+58
New +$2.61K ﹤0.01% 1937
2024
Q2
Sell
-19,841
Closed -$681K 2140
2024
Q1
$681K Buy
19,841
+19,787
+36,643% +$714K ﹤0.01% 1263
2023
Q4
$1.99K Sell
54
-1,354
-96% -$31.3K ﹤0.01% 1928
2023
Q3
$28.5K Buy
+1,408
New +$30.9K ﹤0.01% 1740
2021
Q4
Sell
-162,300
Closed -$17.4M 2307
2021
Q3
$17.4M Hold
162,300
0.03% 510
2021
Q2
$21.6M Hold
162,300
0.04% 457
2021
Q1
$20.1M Sell
162,300
-23,748
-13% -$3.61M 0.04% 496
2020
Q4
$26.3M Sell
186,048
-55,979
-23% -$6.21M 0.05% 401
2020
Q3
$18.4M Sell
242,027
-17,971
-7% -$1.12M 0.04% 431
2020
Q2
$11.8M Buy
259,998
+91,763
+55% +$3.29M 0.03% 499
2020
Q1
$5.14M Sell
168,235
-65,941
-28% -$1.77M 0.02% 620
2019
Q4
$4.92M Hold
234,176
0.01% 777
2019
Q3
$5.59M Sell
234,176
-294,225
-56% -$8.55M 0.01% 753
2019
Q2
$15.3M Sell
528,401
-47
-0% -$1.24K 0.04% 429
2019
Q1
$12.2M Sell
528,448
-80,305
-13% -$1.81M 0.03% 489
2018
Q4
$14.1M Buy
+608,753
New +$13.5M 0.04% 391

Other funds holding TWST

Federated Hermes's TWST Position: Q3 2025 in Review

Federated Hermes sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 15,778 shares — an estimated $580K sold.

Federated Hermes first reported a position in TWST in Q4 2018 and held it in 17 quarters. The position peaked at $26.3M in Q4 2020. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • Federated Hermes reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • Federated Hermes sold 15,778 Twist Bioscience shares in Q3 2025, an estimated $580K.
  • Federated Hermes first reported a position in Twist Bioscience in Q4 2018 and held it in 17 quarters.
  • Federated Hermes's Twist Bioscience position peaked at $26.3M in Q4 2020.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.